Molecular genetic analysis of giant cell glioblastomas

American Journal of Pathology

Volumn 151, Issue 3, 1997, Pages 853-857

  Meyer Puttlitz, Birgit ^a   Hayashi, Yutaka ^a   Waha, Andreas ^a   Rollbrocker, Britta ^a   Boström, Jan ^b   Wiestler, Otmar D ^a   Louis, David N ^c   Reifenberger, Guido ^b   Von Deimling, Andreas ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE AMPLIFICATION; GENE DELETION; GENETIC ANALYSIS; GENETIC VARIABILITY; GIANT CELL; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD;

ADULT; AGED; CARRIER PROTEINS; CHILD; CHROMOSOME ABERRATIONS; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; FEMALE; GENE DELETION; GENES, P53; GIANT CELLS; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0030921607     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Winger MJ, Macdonald DR. Cairncross JG: Supratentorial anaplastic gliomas in adults. J Neurosurg 1989, 71:487-493
2. Kleihues P, Burger PC, Scheithauer BW: Histological Typing of Tumours of the Central Nervous System. New York, Springer-Verlag Berlin, 1993
3. von Deimling A, Eibl RH, Ohgaki H, Louis DN, von Ammon K, Petersen I, Kleihues P, Chung RY, Wiestler OD, Seizinger BR: p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res 1992, 52:2987-2990
4. Fults D, Brockmeyer D, Tullous MW, Pedone CA, Cawthon RM: p53 mutation and loss of heterozygosity on chromosome 17 and 10 during human astrocytoma progression. Cancer Res 1992, 52:674-679
5. Rollbrocker B, Waha A, Louis DN, Wiestler OD, von Deimling A: Amplification of the cyclin dependent kinase 4 (CDK4) gene is associated with high cdk4 protein levels in glioblastoma multiforme. Acta Neuropathol 1996, 92:70-74
6. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS, Collins VP: Amplification of multiple genes from chromosomal region 12q13-q14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS and MDM2. Cancer Res 1994, 54:4299-4303
7. Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP: Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993, 53: 2736-2739
8. von Deimling A, Louis DN, von Ammon K, Petersen I, Hoell T, Chung RY, Martuza R, Schoenfeld D, Yasargil MG, Wiestler OD, Seizinger BR: Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 1992, 77:295-301
9. Giani C, Finocchiaro G: Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res 1994, 54:6338-6339
10. Jen J, Harper W, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW, Vogelstein B: Deletion of p16 and p15 genes in brain tumors. Cancer Res 1994, 54:6353-6358
11. Henson JW, Schnitker BL, Correa KM, von Deimling A, Fassbender F, Xu H-J, Benedict WF, Yandell DW, Louis DN: The retinoblastoma gene is involved in malignant progression of astrocytomas. Ann Neurol 1994, 36:714-721
12. Ueki K, Ono Y, Henson JW, von Deimling A, Louis DN: CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated. Cancer Res 1996, 56:150-153
13. Louis DN, Gusella JF: A tiger behind many doors: multiple genetic pathways to malignant glioma. Trends Genet 1995, 11:412-415
14. von Deimling A, von Ammon K, Schoenfeld D, Wiestler OD, Seizinger BR, Louis DN: Subsets of glioblastoma multiforme defined by molecular genetic analysis. Brain Pathol 1993, 3:19-26
15. Reifenberger J, Ring GU, Gies U, Cobbers JMJL, Oberstrass J, An H-X, Niederacher D, Wechsler W, Reifenberger G: Analysis of p53 mutation and epidermal growth factor receptor amplification in recurrent gliomas with malignant progression. J Neuropathol Exp Neurol 1996, 55:822-831
16. Watanabe K, Tachibana O, Sato K, Yonekawa Y, Kleihues P, Ohgaki H: Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 1996, 6:217-223
17. Zülch KJ: Histological typing of tumours of the central nervous system. International Histological Classification of Tumours, no 21. Geneva, World Health Organization, 1979
18. Palma L, Celli P, Maleci A, Di Lorenzo N, Cantore G: Malignant monstrocellular brain tumours: a study of 42 surgically treated. Acta Neurochir 1989, 97:17-25
19. Mueller W, Slowik F, Firsching R, Afra D, Sanker P: Contribution to the problem of giant cell astrocytomas. Neurosurg Rev 1987, 10:213-219
20. Waha A, Rollbrocker B, Wiestler OD, von Deimling A: A polymerase chain reaction-based assay for the rapid detection of gene amplification in human tumors. Diagn Mol Pathol 1996, 5:147-150
21. Hayashi Y, Ueki K, Waha A, Wiestler OD, Louis DN, von Deimling A: Close association of EGFR amplification and CDKN2 (p16/MTS1) gene deletion in glioblastoma multiforme. Brain Pathol 1997, 7:871-875
22. Wellenreuther R, Kraus J, Lenartz D, Menon AG, Schramm J, Louis DN, Ramesh V, Gusella JF, Wiestler OD, von Deimling A: Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995, 146:827-832
23. Burger PC, Green SB: Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 1987, 59: 1617-1625
24. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stein H: Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol 1987, 74:179-182
25. Brooks WH, Markesbery WR, Gupta GD, Roszman TL: Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978, 4:219-224
26. Palma L, Di Lorenzo N, Guidetti B: Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. J Neurosurg 1978, 49:854-861
27. Burger PC, Vollmer RT: Histologic factors of prognostic significance in the glioblastoma multiforme. Cancer 1980, 46:1179-1186
28. Safdari H, Hochberg FH, Richardson EP Jr: Histological correlations with survival in malignant gliomas. Acta Neurochir Suppl 1979, 28: 485-488
29. Louis DN: The p53 gene and protein in human brain tumors. J Neuropathol Exp Neurol 1994, 53:11-21
30. Bögler O, Huang SH-J, Kleihues P, Cavenee WK: The p53 gene and its role in human brain tumors. Glia 1995, 15:308-327
31. Minn AJ, Boise LH, Thompson CB: Expression of Bcl-xL and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage. Genes Dev 1996, 10:2621-2631
32. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF: Abnormal centrosome amplification in the absence of p53. Science 1996, 271:1744-1747
33. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331
34. van Meyel DJ, Ramsay DA, Casson AG, Keeney M, Chambers AF, Cairncross JG: p53 mutation, expression, and DNA ploidy in evolving gliomas: evidence for two pathways of progression. J Natl Cancer Inst 1994, 86:1011-1017
35. Oda H, Zhang S, Tsurutani N, Shimizu S, Nakatsuru Y, Aizawa S, Ishikawa T: Loss of p53 is an early event in induction of brain tumors in mice by transplacental carcinogen exposure. Cancer Res 1997, 57:646-650
36. Louis DN, Rubio M-P, Correa KM, Gusella JF, von Deimling A: Molecular genetics of pediatric brain stem gliomas: application of PCR techniques to small and archival brain tumor specimens. J Neuropathol Exp Neurol 1993, 52:507-515
37. Nagane M, Coufal F, Lin H, Boegler O, Cavenee WK, Huang H-JS: A common mutant epidermal growth factor receptor confers enhanced tumorigenicity on human glioblastoma cells by increasing proliferation and reducing apoptosis. Cancer Res 1996, 56:5079-5089
38. Ono Y, Tamiya T, Ichikawa T, Kunishio K, Matsumoto K, Furuta T, Ohmoto T, Ueki K, Louis DN: Malignant astrocytomas with homozygous CDKN2/p16 gene deletions have higher Ki-67 proliferation indices. J Neuropathol Exp Neurol 1996, 55:1026-1031